HCRT and diabetes mellitus: Future advances in our understanding of the common pathological features of stroke, diabetes, and narcolepsy, as well as the mechanisms of hypocretin-associated protection, may point to the possibility of using hypocretins to treat these diseases [151] (Figure 3).